✦ LIBER ✦

787 EFFECTS OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF BRIVANIB IN A PHASE I, OPEN-LABEL, MULTIDOSE STUDY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND OTHER SOLID TUMORS

✍ Scribed by A. El-Khoueiry; H.J. Lenz; J. Posey; T. Wood; B. Fischer; V. Sankar; S. Shariq; G. Kollia; E. Masson; I. Walters

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a phase I, open-label, random

✍ Chiu, Yi-Lin; LoRusso, Patricia; Hosmane, Balakrishna; Ricker, Justin L.; Awni, 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 287 KB

Phase I study to assess the pharmacokine

✍ Nianhang Chen, Sant P. Chawla… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 600 KB

510 Pharmacokinetics (PK) and effects on

✍ L. Pendyala; P. Smith; M. Fakih; P. Creaven; J. Prey; M. Murphy; Y. Rustum 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Effect of the CYP3A inhibitor ketoconazo

✍ Karthik Venkatakrishnan; Michael Rader; Ramesh K. Ramanathan; Suresh Ramalingam; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A phase I, open-label, randomized crosso

✍ Suzanne Leijen; Patricia M. M. B. Soetekouw; T. R. Jeffry Evans; Marianne Nicols 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 303 KB

411 POSTER A phase I, open-label, dose-e

✍ R. Salgia; A. Peterson; S. Eppler; W. Yu; B. Polite; D. Geary; E. Wesolowski; M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB